ClinicalTrials.gg

What’s New Sign In

Drug

Epoetin beta clinical trials

studies test it: 40
open now: 0
in phase 3: 12
first study started: 1998

How studies write it

Studies that test it under each name

Name

Epoetin beta: 23
NeoRecormon: 15
Recormon: 7
epoetin beta [NeoRecormon]: 5
Epoetin beta (NeoRecormon): 2

Combined with it in one product

Neo-Recormon and Venofer: 1

Studies by the year they started

37 studies that test it; most in 2007 (6)

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 8
Phase 3: 12
Phase 4: 17
No phase: 3

What it is tested for

Each study’s main condition, where its own words name it.

Anemia: 12
Myelodysplastic Syndromes: 5
Kidney Failure, Chronic: 4
Acute Kidney Injury: 2
Renal Insufficiency: 1
Diabetic Nephropathies: 1
Hepatitis C, Chronic: 1
Uterine Cervical Neoplasms: 1
Myocardial Ischemia: 1
Kidney Diseases: 1
Multiple Myeloma: 1
Neoplasms: 1

Who runs them

Industry 20 · Other 20

Hoffmann-La Roche (17) · Groupe Francophone des Myelodysplasies (3) · Centre Hospitalier Universitaire, Amiens (2) · Seoul National University Bundang Hospital (2) · Imperial College Healthcare NHS Trust (1) · Imperial College London (1) · University Hospital, Angers (1) · JW Pharmaceutical (1)

Often tested with

Tested in the same studies.

Iron sucrose (3) · Lenalidomide (1) · Mycophenolic Acid (1) · Prednisone (1) · Cisplatin (1) · Epoetin Alfa (1)

Studies

Open first, then newest update. How each study uses epoetin beta is read from its arms, and is right about nine times in ten.

Testing it · 40

See all 40 studies that test epoetin beta →

Given in every arm · 3 — epoetin beta is usual care beside what is tested

As the comparator · 7 — what is tested is compared with epoetin beta